Oral pulsed dexamethasone therapy in early rheumatoid arthritis: A pilot study

Annals of the New York Academy of Sciences

Volumn 1069, Issue , 2006, Pages 300-306

  Kroot, Eric Jan A ^a   Huisman, A Margriet ^a   Van Zeben, Jendé ^a   Wouters, Jacques M G W ^a   Van Paassen, Henk C ^a  

^a SINT FRANCISCUS GASTHUIS   (Netherlands)

Author keywords

Oral pulsed dexamethasone; Rheumatoid arthritis; Therapy

Indexed keywords

DEXAMETHASONE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG PULSE THERAPY; DRUG SAFETY; FEMALE; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; RHEUMATOID ARTHRITIS; SIDE EFFECT; WEIGHT GAIN;

EID: 33744753850     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1351.028     Document Type: Conference Paper

References (14)

1. LAAN, R.F., T.L. JANSEN & P.L.C.M. VAN RIEL. 1999. Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology 38: 6-12.
2. DA SILVA, J.A. & J.W. BIJLSMA. 2000. Optimizing glucocorticoid therapy in rheumatoid arthritis. Rheum. Dis. Clin. N. Amer. 26: 859-880.
3. VAN EVERDINGEN, A.A., J.W. JACOBS, D.R. SIEWERTSZ VAN REESEMA & J.W. BIJLSMA. 2002. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann. Intern. Med. 136: 1-12.
4. BOERS, M., A.C. VERHOEVEN, H.M. MARKUSSE, et al. 1997. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 350: 309-318.
5. FREDIANI, B., P. FALSETTI, S. BISOGNO, et al. 2004. Effects of high dose methyl-prednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study. J. Rheumatol. 31: 1083-1087.
6. ANDERSEN, J. C. 1994. Response of resistant idiopathic thrombocytopenic purpura to pulsed high-dose dexamethasone therapy. N. Engl. J. Med. 330: 1560-1564.
7. MOLENAAR, D.S., P.A. VAN DOORN, M. VERMEULEN. 1997. Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study. J. Neurol. Neurosurg. Psychiatry 62: 388-390.
8. VAN DER MEULEN, M.F., J.E. HOOGENDIJK, J.H. WOKKE & M.DE. VISSER. 2000. Oral pulsed high-dose dexamethasone for myositis. J. Neurol. 247: 102-105.
9. WENTING-VAN WIJK, M.J., M.A. BLANKENSTEIN, F.P. LAFEBER & J.W. BIJLSMA. 1999. Relation of plasma dexamethasone to clinical response. Clin. Exp. Rheumatol. 17: 305-312.
10. BERTOUCH, J.V., P.J. ROBERTS-THOMSON, M.D. SMITH, et al. 1986. Methylprednisolone infusion therapy in rheumatoid arthritis patients: the effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum. 29: 32-38.
11. NOSSENT, H.C., G. BAKLAND, H.K. ASLAKSEN, et al. 2001. Efficacy of methylprednisolone pulse therapy versus infliximab in the treatment of severe flares of chronic polyarthritis. Scand. J. Rheumatol. 30: 335-339.
12. JACOBS, J.W., R. GEENEN, A.W. EVERS, et al. 2001. Short term effects of corticosteroid pulse treatment on disease activity and the wellbeing of patients with active rheumatoid arthritis. Ann. Rheum. Dis. 60: 61-64.
13. SONG, I.H., R. GOLD, R.H. STRAUB, et al. 2005. New glucocorticoids on the horizon: repress, don't activate! J. Rheumatol. 32: 1199-1207.
14. BUTTGEREIT, F., R.H. STRAUB, M. WEHLING & G.R. BURMESTER. 2004. Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action. Arthritis Rheum. 50: 3408-3417.